These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 8140941)

  • 1. Course of bone mass during and after hormonal replacement therapy with and without addition of nandrolone decanoate.
    Erdtsieck RJ; Pols HA; van Kuijk C; Birkenhäger-Frenkel DH; Zeelenberg J; Kooy PP; Mulder P; Birkenhäger JC
    J Bone Miner Res; 1994 Feb; 9(2):277-83. PubMed ID: 8140941
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of combined treatment with etidronate, nandrolone-decanoate and calcium on bone mineral density in postmenopausal women.
    Bolanca S; Korsić M; Dekanić D; Cvijetić S
    Acta Med Croatica; 1998; 52(3):159-63. PubMed ID: 9818438
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epidemiology, biochemistry and some results with treatment of postmenopausal osteoporosis.
    Hassager C; Christiansen C
    Wien Med Wochenschr; 1993; 143(14-15):389-91. PubMed ID: 8256454
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of nandrolone decanoate and antiresorptive therapy on vertebral density in osteoporotic postmenopausal women.
    Need AG; Horowitz M; Bridges A; Morris HA; Nordin BE
    Arch Intern Med; 1989 Jan; 149(1):57-60. PubMed ID: 2912415
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of nandrolone therapy on forearm bone mineral content in osteoporosis.
    Need AG; Horowitz M; Morris HA; Walker CJ; Nordin BE
    Clin Orthop Relat Res; 1987 Dec; (225):273-8. PubMed ID: 3677513
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of protein-rich supplementation and nandrolone on bone tissue after a hip fracture.
    Tengstrand B; Cederholm T; Söderqvist A; Tidermark J
    Clin Nutr; 2007 Aug; 26(4):460-5. PubMed ID: 17498850
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The metabolic and bone density effects of continuous combined 17-beta estradiol and noresthisterone acetate treatments in Thai postmenopausal women: a double-blind placebo-controlled trial.
    Bunyavejchevin S; Limpaphayom KK
    J Med Assoc Thai; 2001 Jan; 84(1):45-53. PubMed ID: 11281499
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anabolic steroids in corticosteroid-induced osteoporosis.
    Adami S; Rossini M
    Wien Med Wochenschr; 1993; 143(14-15):395-7. PubMed ID: 8256456
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nandrolone decanoate treatment of post-menopausal osteoporosis for 2 years and effects of withdrawal.
    Hassager C; Riis BJ; Pødenphant J; Christiansen C
    Maturitas; 1989 Dec; 11(4):305-17. PubMed ID: 2693918
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The influence of hormonal replacement therapy on bone density in postmenopausal women depending on polymorphism of vitamin D receptor (VDR) and estrogen receptor (ER) genes].
    Brodowska A
    Ann Acad Med Stetin; 2003; 49():111-30. PubMed ID: 15552843
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nandrolone decanoate and intranasal calcitonin as therapy in established osteoporosis.
    Flicker L; Hopper JL; Larkins RG; Lichtenstein M; Buirski G; Wark JD
    Osteoporos Int; 1997; 7(1):29-35. PubMed ID: 9102059
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of nandrolone decanoate therapy on weight and lean body mass in HIV-infected women with weight loss: a randomized, double-blind, placebo-controlled, multicenter trial.
    Mulligan K; Zackin R; Clark RA; Alston-Smith B; Liu T; Sattler FR; Delvers TB; Currier JS; ;
    Arch Intern Med; 2005 Mar; 165(5):578-85. PubMed ID: 15767536
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anabolic steroids in postmenopausal osteoporosis.
    Need AG; Durbridge TC; Nordin BE
    Wien Med Wochenschr; 1993; 143(14-15):392-5. PubMed ID: 8256455
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Can nandrolone add to the effect of hormonal replacement therapy in postmenopausal osteoporosis?
    Birkenhäger JC; Erdtsieck RJ; Zeelenberg J; van Kuik C; van Veen LC; Birkenhäger-Frenkel DH; Luiken GP; Kooy PP; Gerritsma EJ; Mulder P
    Bone Miner; 1992 Sep; 18(3):251-65. PubMed ID: 1392698
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of nandrolone decanoate on bone mass in established osteoporosis.
    Passeri M; Pedrazzoni M; Pioli G; Butturini L; Ruys AH; Cortenraad MG
    Maturitas; 1993 Nov; 17(3):211-9. PubMed ID: 8133796
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of nandrolone decanoate therapy on bone mass and calcium metabolism in women with established post-menopausal osteoporosis: a double-blind placebo-controlled study.
    Gennari C; AgnusDei D; Gonnelli S; Nardi P
    Maturitas; 1989 Sep; 11(3):187-97. PubMed ID: 2687645
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of nandrolone decanoate compared with placebo or testosterone on HIV-associated wasting.
    Gold J; Batterham MJ; Rekers H; Harms MK; Geurts TB; Helmyr PM; Silva de Mendonça J; Falleiros Carvalho LH; Panos G; Pinchera A; Aiuti F; Lee C; Horban A; Gatell J; Phanuphak P; Prasithsirikul W; Gazzard B; Bloch M; Danner SA;
    HIV Med; 2006 Apr; 7(3):146-55. PubMed ID: 16494628
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The carboxy-terminal pyridinoline cross-linked telopeptide of type I collagen in serum as a marker of bone resorption: the effect of nandrolone decanoate and hormone replacement therapy.
    Hassager C; Jensen LT; Pødenphant J; Thomsen K; Christiansen C
    Calcif Tissue Int; 1994 Jan; 54(1):30-3. PubMed ID: 8118750
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of postmenopausal osteoporosis: is the anabolic steroid nandrolone decanoate a candidate?
    Johansen JS; Hassager C; Pødenphant J; Riis BJ; Hartwell D; Thomsen K; Christiansen C
    Bone Miner; 1989 Apr; 6(1):77-86. PubMed ID: 2665884
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Double-blind placebo--controlled trial of nandrolone decanoate in postmenopausal osteoporosis.
    Chhaparwal M; Saraf ML
    Indian J Med Sci; 1998 Jun; 52(6):236-8. PubMed ID: 9849033
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.